A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
Clinical trial NCT03549871 · COMPLETED
Trial details
- NCT number
- NCT03549871
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2022-01-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.